LISATA THERAPEUTICS, INC.

BiotechnologyBiotechnologyClinical-stageOncology

📍 Basking Ridge, NJ, US• Founded 2006• 34 employees

StreetZero Signal 86

Be the first to signal interest

About LISATA THERAPEUTICS, INC.

Lisata Therapeutics, Inc. is a U.S. clinical-stage pharmaceutical company (Nasdaq: LSTA) dedicated to the discovery, development, and commercialization of innovative therapies for the treatment of advanced solid tumors and other major diseases. The company is headquartered in Basking Ridge, New Jersey, and was founded in 2006. It recently announced the acquisition of Marea Therapeutics along with a concurrent private placement.

LATEST FUNDINGPrivate Placement

$351.9M

Announced 2026-10-02

TOTAL RAISED$166M

🔒

Unlock the full deal profile

Create a free account to see investors, key highlights, news, company details and the AI analysis for LISATA THERAPEUTICS, INC..

Create free account Sign in

Free plan includes 3 full deal profiles every month.

IN THE NEWS

EMPLOYEES34

FOUNDED2006

HQBasking Ridge, NJ, US

Industry

Biotechnology

Investors

Sofinnova Investments, Inc.

Key highlights

Announced $225 million private placement in September 2026 concurrent with Marea acquisition.
Clinical-stage company with Nasdaq listing LSTA focused on solid tumor therapies.
Acquired Marea Therapeutics bringing MAR001 for severe hypertriglyceridemia into pipeline.
Based in Basking Ridge, NJ with approximately 34 employees and $5.3 million in reported revenue.